Evidence map›Paper›PMID 32440496›Full record

ReviewJournal of orthopaedic translation2020

Recent developments in biomaterials for long-bone segmental defect reconstruction: A narrative overview.

Meng Zhang, Jukka P Matinlinna, James K H Tsoi, Wenlong Liu, Xu Cui, William W Lu, Haobo Pan

Open access · goldAbstract readReview
In one paragraph

Review in Journal of orthopaedic translation, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 1 pooled it
5.4field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 1 synthesis or guideline pooled it, 100 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Signalling pathways underlying pulsed electromagnetic fields in bone repair.Frontiers in bioengineering and biotechnology · 2024
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Meng ZhangResearch Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen University Town, Shenzhen, 518055, China.
Jukka P MatinlinnaApplied Oral Sciences, Faculty of Dentistry, The University of Hong Kong, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR, China.
James K H TsoiApplied Oral Sciences, Faculty of Dentistry, The University of Hong Kong, 34 Hospital Road, Sai Ying Pun, Hong Kong SAR, China.
Wenlong LiuResearch Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen University Town, Shenzhen, 518055, China.
Xu CuiResearch Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen University Town, Shenzhen, 518055, China.
William W LuResearch Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen University Town, Shenzhen, 518055, China.
Haobo PanResearch Center for Human Tissues and Organs Degeneration, Institute of Biomedicine and Biotechnology, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, 1068 Xueyuan Avenue, Shenzhen University Town, Shenzhen, 518055, China.
Chinese Academy of Sciences · CNShenzhen Institutes of Advanced Technology · CNUniversity of Hong Kong · HK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Reconstruction of long-bone segmental defects (LBSDs) has been one of the biggest challenges in orthopaedics. Biomaterials for the reconstruction are required to be strong, osteoinductive, osteoconductive, and allowing for fast angiogenesis, without causing any immune rejection or disease transmission. There are four main types of biomaterials including autograft, allograft, artificial material, and tissue-engineered bone. Remarkable progress has been made in LBSD reconstruction biomaterials in the last ten years. THE TRANSLATIONAL POTENTIAL OF THIS ARTICLE: Our aim is to summarize recent developments in the divided four biomaterials utilized in the LBSD reconstruction to provide the clinicians with new information and comprehension from the biomaterial point of view.

Indexed as

ADSC, allogenic adipose-derived stem cellsAllograftALLO, partially demineralized allogeneic bone blockALP, alkaline phosphataseArtificial materialASC, adipose-derived stem cellAutograftbFGF, basic Fibroblast Growth FactorBiomaterialBMP-2 & 4, bone morphogenetic protein-2 & 4BMSC, bone marrow–derived mesenchymal stem cellBV, baculovirusCS, chitosanDBM, decalcified bone matrixFGF-2, Fibroblast Growth Factor-2HDB, heterogeneous deproteinized bonehtMSCs, human tubal mesenchymal stem cellsLBSD, long-bone segmental defectLong-bone segmental defect reconstructionM-CSF, macrophage colony-stimulating factorMIC, fresh marrow-impregnated ceramic blockMSC, autologous mesenchymal stem cellsnHA, nano-hydroxyapatitePCL, polycaprolactonePDGF, Platelet-Derived Growth FactorPDLLA, poly(DL-lactide)PET/CT, positron emission- and computed tomographyPLA, poly(lactic acid)poly, (L-lactide-co-D,L-lactide)PPF, propylene fumaraterADSC, rabbit adipose-derived mesenchymal stem cellrhBMP-2, recombinant human bone morphogenetic protein-2rhBMP-7, recombinant human bone morphogenetic protein 7rVEGF-A, recombinant vascular endothelial growth factor-ASF, silk fibroinsRANKL, soluble RANKLTCP, tricalcium phosphateTEB, combining ceramic block with osteogenic-induced mesenchymal stem cells and platelet-rich plasmaTGF-β, Transforming Growth Factor-βTissue engineeringVEGF, Vascular Endothelial Growth Factorβ-TCP, β-tricalcium phosphate

Identifiers

PMID32440496
PMCPMC7231954
OpenAlexW2979875785

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.